Back
ACVC Premium Access

Are there clinical implications of an antiphospholipid syndrome diagnosis in pulmonary embolism patients?

Session: Poster Session 2 - DVT and pulmonary embolism
Topic: Thrombosis / embolism
Speaker: Doctor D. Candeias Faria (Faro, PT)
Event: Acute Cardiovascular Care 2016

Congress Presentation

About the speaker

Doctor Daniel Alexandre Candeias Faria

University Hospital Center of Algarve, Faro (Portugal)
2 presentations
1 follower

5 more presentations in this session

1 year prognosis in acute pulmonary embolism: validation of PESI and sPESI prognostic models.

Speaker: Miss J. Neiva (Viana do Castelo, PT)

Access
Abstract
Thumbnail

Eligibility criteria for non-vitamin K antagonist anticoagulants in patients with pulmonary embolism in a real world portuguese population

Speaker: Doctor D. Candeias Faria (Faro, PT)

Access
Abstract
Thumbnail

Propensity score adjusted analysis of the association of thrombolytic therapy and 30-days outcome in patients with intermediate risk pulmonary embolism

Speaker: Professor N. Radovanovic (Belgrade, RS)

Access
Abstract
Thumbnail

Reperfusion therapies for acute pulmonary embolism: the experience of a center

Speaker: Doctor A. Barbosa (Santa Maria da Feira, PT)

Access
Abstract
Thumbnail

Thrombolytic therapy for pulmonary embolism in real clinical practice

Speaker: Associate Professor I. Pochinka (Nizhny Novgorod, RU)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 2 - DVT and pulmonary embolism

Speakers: Doctor D. Candeias Faria, Miss J. Neiva, Doctor D. Candeias Faria, Professor N. Radovanovic, Doctor A. Barbosa...
Access
Thumbnail

About the event

Image

Acute Cardiovascular Care 2016

15 October - 17 October 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb